Institutional investors control 14.29% of the outstanding shares in AZN. This represents a greater percentage of ownership than at almost any other company in the Pharmaceuticals: Major industry. Additionally, during the quarter ended March 2017, these large investors purchased a net $42.0 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
PRIMECAP MANAGEMENT CO. Bought 8.3 Million shares of AstraZeneca
MANAGED ACCOUNT ADVISORS LLC Bought 8.0 Million shares of AstraZeneca
DODGE & COX Bought 7.3 Million shares of AstraZeneca